These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14597939)

  • 1. Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Sattelberger U; Dirschinger J; Schömig A
    Am Heart J; 2003 Nov; 146(5):882-6. PubMed ID: 14597939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].
    Kastrati A; Mehilli J; Dirschinger J; Dotzer F; Schuhlen H; Neumann FJ; Fleckenstein M; Pfafferott C; Seyfarth M; Schomig A
    Vestn Rentgenol Radiol; 2012; (2):52-60. PubMed ID: 22730760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.
    Pache J; Kastrati A; Mehilli J; Schühlen H; Dotzer F; Hausleiter J; Fleckenstein M; Neumann FJ; Sattelberger U; Schmitt C; Müller M; Dirschinger J; Schömig A
    J Am Coll Cardiol; 2003 Apr; 41(8):1283-8. PubMed ID: 12706922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.
    Kastrati A; Mehilli J; Dirschinger J; Dotzer F; Schühlen H; Neumann FJ; Fleckenstein M; Pfafferott C; Seyfarth M; Schömig A
    Circulation; 2001 Jun; 103(23):2816-21. PubMed ID: 11401938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of the American College of Cardiology/American Heart Association angiographic classification of coronary lesion morphology in patients with in-stent restenosis. Insights from the Restenosis Intra-stent Balloon angioplasty versus elective Stenting (RIBS) randomized trial.
    Alfonso F; Cequier A; Angel J; Martí V; Zueco J; Bethencourt A; Mantilla R; López-Minguez JR; Gómez-Recio M; Morís C; Perez-Vizcayno MJ; Fernández C; Macaya C; Seabra-Gomes R;
    Am Heart J; 2006 Mar; 151(3):681.e1-681.e9. PubMed ID: 16504631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-stent restenosis in small coronary arteries: impact of strut thickness.
    Briguori C; Sarais C; Pagnotta P; Liistro F; Montorfano M; Chieffo A; Sgura F; Corvaja N; Albiero R; Stankovic G; Toutoutzas C; Bonizzoni E; Di Mario C; Colombo A
    J Am Coll Cardiol; 2002 Aug; 40(3):403-9. PubMed ID: 12142103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.
    Pache J; Dibra A; Mehilli J; Dirschinger J; Schömig A; Kastrati A
    Eur Heart J; 2005 Jul; 26(13):1262-8. PubMed ID: 15737962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization.
    Ortolani P; Marzocchi A; Marrozzini C; Palmerini T; Saia F; Taglieri N; Aquilina M; Baldazzi F; Silenzi S; Cooke RM; Reggiani ML; Branzi A
    Catheter Cardiovasc Interv; 2007 May; 69(6):790-8. PubMed ID: 17290437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long-term results.
    Rodriguez A; Rodríguez Alemparte M; Fernández Pereira C; Sampaolesi A; da Rocha Loures Bueno R; Vigo F; Obregón A; Palacios IF;
    Am J Med; 2005 Jul; 118(7):743-51. PubMed ID: 15989908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent.
    Silenzi S; Grossi P; Mariani L; Fraccaro C; Vagnarelli F; Moretti L
    J Interv Cardiol; 2016 Jun; 29(3):300-10. PubMed ID: 27242170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of strut thickness on late luminal loss after coronary artery stent placement.
    Rittersma SZ; de Winter RJ; Koch KT; Bax M; Schotborgh CE; Mulder KJ; Tijssen JG; Piek JJ
    Am J Cardiol; 2004 Feb; 93(4):477-80. PubMed ID: 14969629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
    Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A;
    Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the quantitative coronary angiographic analysis in the angiographic subgroup of the Multi-Link 2.5 Portuguese Registry.
    Seabra-Gomes R; Almeida M; Cavaco D; Bettencourt V; Baptista J; Marques AL; Pereira H; Farto e Abreu P; dos Santos LP
    Rev Port Cardiol; 2001 Sep; 20(9):841-55. PubMed ID: 11763596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
    Kufner S; Byrne RA; Mehilli J; Massberg S; Birkmeier KA; Schulz S; Pache J; Schömig A; Kastrati A
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E769-76. PubMed ID: 23754254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stent length and lesion length on coronary restenosis.
    Mauri L; O'Malley AJ; Cutlip DE; Ho KK; Popma JJ; Chauhan MS; Baim DS; Cohen DJ; Kuntz RE
    Am J Cardiol; 2004 Jun; 93(11):1340-6, A5. PubMed ID: 15165911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
    Sick PB; Brosteanu O; Ulrich M; Thiele H; Niebauer J; Busch I; Schuler G
    Am Heart J; 2005 Apr; 149(4):681-8. PubMed ID: 15990753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
    Schühlen H; Kastrati A; Mehilli J; Hausleiter J; Dirschinger J; Dotzer F; Bollwein H; Schömig A
    Am Heart J; 2006 Jun; 151(6):1248-54. PubMed ID: 16781230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents.
    Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE
    Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of device selection on angiographic outcomes for the treatment of in-stent restenosis. A sub analysis from the Washington Radiation for In-Stent restenosis Trial (WRIST).
    Zimarino M; Ajani AE; Marazia S; Pichard AD; Satler LF; De Caterina R; Barsotti A; Waksman R
    Ital Heart J; 2002 Apr; 3(4):256-62. PubMed ID: 12025375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.